Where can researchers source third-party tested CJC-1295?

Midwest Peptide supplies research-grade CJC-1295 with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

CJC-1295 Peptide Research: Growth Hormone, IGF-1 & Metabolism | Midwest Peptide

Where to Buy GLP-3 RT Online for Research Use in 2026Prev|BPC-157 in Research: What It Is, What It Does, and How It's UsedNext

CJC-1295 in Research: What It Is, What It Does, and How It's Used

CJC-1295 / Ipamorelin · Published March 28, 2026 · Updated April 28, 2026 · 8 min read

Quick Answer

CJC-1295 is a stabilized growth hormone releasing hormone analog used in preclinical research to study the GH axis, IGF-1 signaling, metabolic regulation, and aging-related endpoints. Studies examine pulsatile GH release, somatotroph activation, and downstream biomarker dynamics across rodent models. For research use only, not for human consumption.

CJC-1295 in Research: What It Is, What It Does, and How It's Used

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

How CJC-1295 Works at the Cellular Level
What Is CJC-1295 Used to Study?
Important Experimental Considerations
Quality and Transparency Standards
Final Thoughts
External References
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), a naturally occurring hormone produced in the hypothalamus that signals the pituitary gland to release growth hormone (GH). CJC-1295 was developed to address the key limitation of natural GHRH — its extremely short half-life of just a few minutes in biological systems. Through a process called Drug Affinity Complex (DAC) technology, CJC-1295 is engineered to bind to albumin, a protein naturally present in the bloodstream, which dramatically extends its active lifespan and makes it a far more practical tool for research applications.

Frequently Asked Questions

What is CJC-1295 in research contexts?

CJC-1295 is a synthetic 30-amino-acid analog of growth hormone-releasing hormone (GHRH). It is studied in research models as a long-acting GHRH receptor agonist that drives pulsatile growth hormone release from the pituitary.

What pathways does CJC-1295 activate in research?

CJC-1295 binds the GHRH receptor on pituitary somatotrophs, activating Gs-coupled adenylyl cyclase signaling, raising cAMP, and stimulating growth hormone synthesis and pulsatile release. Downstream, IGF-1 is elevated through hepatic GH receptor signaling.

How does CJC-1295 differ from native GHRH in research models?

Native GHRH has a half-life of minutes due to DPP-IV cleavage. CJC-1295 contains amino acid substitutions that confer DPP-IV resistance, and the DAC-modified form binds albumin to extend half-life to days, enabling sustained signaling not achievable with native GHRH.

Is CJC-1295 approved for human use?

No. CJC-1295 is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Glossary

Key terms used in this article.

GHRH: Growth hormone-releasing hormone, the hypothalamic peptide that stimulates pituitary growth hormone release.
DAC (Drug Affinity Complex): A maleimidopropionic acid linker on CJC-1295 that covalently binds serum albumin to extend half-life.
Pulsatile Release: The episodic, rhythmic secretion pattern characteristic of growth hormone from the anterior pituitary.
Pituitary Somatotroph: The anterior pituitary cell type that synthesizes and secretes growth hormone.
IGF-1: Insulin-like growth factor 1, the primary downstream mediator of growth hormone action, produced largely in the liver.
DPP-IV: Dipeptidyl peptidase IV, the enzyme that rapidly inactivates GHRH and many other peptide hormones.
cAMP: Cyclic adenosine monophosphate, the second messenger downstream of Gs-coupled receptors including the GHRH receptor.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

CJC-1295 is used in preclinical research to study the growth hormone axis, pituitary function, metabolic regulation, and the downstream biological effects of sustained GH and IGF-1 elevation. Its stability and predictable pharmacodynamic profile make it one of the most widely used GHRH analogs in research settings.

For Research Use Only. CJC-1295 is intended exclusively for laboratory and preclinical research. It is not approved for human use and should never be administered to humans.

How CJC-1295 Works at the Cellular Level

CJC-1295 works by binding to GHRH receptors (GHRHR) on somatotroph cells in the anterior pituitary gland. These are the cells responsible for producing and releasing growth hormone. When GHRH receptors are activated, a cAMP-mediated signaling cascade is triggered inside the somatotroph cell, ultimately leading to the synthesis and secretion of growth hormone into the bloodstream.

Growth hormone then travels to the liver and other tissues, where it stimulates the production of insulin-like growth factor 1 (IGF-1). IGF-1 is responsible for many of the downstream anabolic and tissue-building effects associated with growth hormone signaling — including protein synthesis, cell proliferation, and fat metabolism.

What makes CJC-1295 particularly useful in research is that its albumin-binding DAC technology allows it to maintain GHRH receptor stimulation over an extended period rather than the brief pulse that natural GHRH produces. This sustained stimulation makes it easier to study the biological consequences of prolonged GH and IGF-1 elevation in research models.

What Is CJC-1295 Used to Study?

Growth Hormone Axis Research

The most fundamental application of CJC-1295 in research is studying the growth hormone axis — the signaling chain that runs from the hypothalamus through the pituitary gland to peripheral tissues. CJC-1295 gives researchers a reliable way to activate this axis in a controlled and sustained manner.

Researchers use CJC-1295 in growth hormone axis studies to:

Examine how sustained GHRH receptor activation affects GH secretion patterns in animal models
Study the relationship between GH pulse frequency, amplitude, and downstream IGF-1 production
Investigate pituitary somatotroph cell biology, including receptor regulation and desensitization following prolonged stimulation
Model conditions of GH deficiency and study whether CJC-1295 can restore normal GH axis function in those models
Examine feedback mechanisms between IGF-1 and the hypothalamus-pituitary axis

Metabolic Research

Growth hormone plays a central role in metabolic regulation, influencing how the body handles fat, glucose, and protein. CJC-1295 is used in metabolic research to study how GH and IGF-1 elevation affects these processes in preclinical models.

Research applications in this area include:

Studying how CJC-1295-driven GH elevation affects lipid metabolism and fat tissue breakdown (lipolysis) in animal models
Examining changes in glucose uptake and insulin sensitivity following sustained GH axis activation
Investigating the relationship between GH signaling and lean muscle mass preservation in models of aging or caloric restriction
Studying how CJC-1295 influences body composition markers in preclinical metabolic research
Examining interactions between the GH axis and other metabolic hormones such as insulin and leptin

Muscle and Tissue Growth Research

IGF-1, produced downstream of GH signaling, is one of the most potent drivers of muscle cell proliferation and protein synthesis known in biology. CJC-1295's ability to reliably elevate IGF-1 levels makes it a valuable tool for researchers studying anabolic signaling in muscle and other tissues.

Researchers use CJC-1295 in muscle and tissue research to:

Study how IGF-1 elevation driven by CJC-1295 affects satellite cell activation — the muscle stem cells responsible for muscle repair and growth
Examine changes in protein synthesis rates in muscle tissue following CJC-1295 exposure
Investigate how sustained GH and IGF-1 signaling influences connective tissue remodeling, including tendon and ligament biology
Study bone density and bone remodeling responses to CJC-1295-driven GH axis activation in animal models
Examine organ growth responses to sustained IGF-1 elevation across different tissue types

Aging and Longevity Research

Growth hormone secretion naturally declines with age — a process sometimes referred to as somatopause. This decline is associated with changes in body composition, metabolic function, and tissue repair capacity. CJC-1295 is used in aging research to model the effects of restored GH axis activity and study whether these changes are reversible.

Key research questions in this area include:

Whether CJC-1295-driven GH restoration in aged animal models reverses or attenuates age-associated changes in body composition
How restored IGF-1 levels affect cellular senescence markers and tissue repair capacity in aging models
Whether sustained GHRH receptor activation in aged animals produces the same downstream effects as in younger animals, or whether receptor sensitivity declines with age
How CJC-1295 interacts with other aging-related biological pathways, including oxidative stress and inflammatory signaling

Pituitary Function Research

CJC-1295 is a useful tool for researchers studying pituitary gland biology directly. The anterior pituitary is a complex endocrine organ, and understanding how somatotroph cells respond to sustained versus pulsatile GHRH stimulation has implications for understanding both normal pituitary function and pituitary pathology.

Research applications include:

Studying somatotroph cell proliferation and GH gene expression in response to CJC-1295 stimulation
Examining GHRH receptor regulation, including upregulation and downregulation in response to sustained ligand exposure
Investigating how CJC-1295 interacts with somatostatin — the inhibitory hormone that counterbalances GHRH signaling in the pituitary
Using CJC-1295 as a research tool in models of pituitary insufficiency or GH deficiency

Important Experimental Considerations

Distinguish between GH-mediated and IGF-1-mediated effects.
Many of the downstream effects of CJC-1295 are not direct — they are mediated through IGF-1 produced in the liver and other tissues in response to GH. Designing experiments that can separate direct GH receptor effects from IGF-1-driven secondary effects will improve the mechanistic precision of your findings. IGF-1 receptor blockers can be useful tools for this purpose.

Account for pulsatile vs. sustained signaling.
Natural GHRH produces pulsatile GH release, while CJC-1295's DAC technology produces more sustained stimulation. This difference in signaling dynamics may produce different biological outcomes than natural GH pulsatility. Consider this when interpreting results and designing protocols that aim to mimic physiological conditions.

Monitor for receptor desensitization.
Sustained GHRH receptor activation can lead to receptor downregulation over time, reducing the pituitary's responsiveness to stimulation. Build time points into your experimental design that allow you to track changes in receptor sensitivity across the duration of your study.

Use appropriate controls.
Always include vehicle-matched controls. Where mechanistic questions are being addressed, consider including GH receptor antagonists or IGF-1 neutralizing antibodies to isolate specific pathway contributions to observed effects.

Match your readouts to your research question.

Studying GH axis activity? Measure serum GH and IGF-1 levels at multiple time points.
Studying metabolic effects? Use glucose tolerance tests, lipid panels, and body composition analysis.
Studying muscle or tissue growth? Use histological analysis, protein synthesis assays, and organ weight measurements.
Studying pituitary biology? Examine somatotroph cell number, GH gene expression, and GHRH receptor density.

Quality and Transparency Standards

At Midwest Peptide, our CJC-1295 is supplied with full quality documentation to support rigorous research protocols:

Third-party HPLC testing for identity and purity verification
Certificate of Analysis (COA) with QR code for complete batch traceability
Manufactured in U.S.-based facilities under strict quality protocols
Detailed batch documentation supporting reproducible research

Final Thoughts

CJC-1295 is a well-characterized and widely used GHRH analog that gives researchers a reliable and practical way to study the growth hormone axis and its downstream biological effects. Its extended half-life through DAC technology makes it significantly more practical than native GHRH for research applications requiring sustained receptor activation.

From foundational GH axis biology to metabolic research, muscle physiology, aging models, and pituitary function, CJC-1295 serves as a versatile and reproducible research tool. Researchers who understand its mechanism and design experiments with appropriate controls and readouts are well positioned to generate meaningful, mechanistically precise data.

CJC-1295 is supplied by Midwest Peptide for research use only and is not intended for human administration.

External References

Primary literature and topic hubs from peer-reviewed publishers covering this area of research:

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

CJC-1295/Ipamorelin Blend — 99%+ purity, COA included
Tesamorelin — 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

CJC-1295 in Research: What It Is, What It Does, and How It's Used